Primary |
Product Used For Unknown Indication |
17.0% |
Pyrexia |
9.2% |
Headache |
8.3% |
Pain |
8.3% |
Drug Use For Unknown Indication |
6.2% |
Hypertension |
6.2% |
Arthritis |
5.7% |
Arthralgia |
5.5% |
Depression |
5.1% |
Blood Pressure |
4.1% |
Diabetes Mellitus |
4.1% |
Analgesic Therapy |
3.0% |
Insomnia |
3.0% |
Anticoagulant Therapy |
2.5% |
Cardiac Disorder |
2.5% |
Thyroid Disorder |
2.3% |
Blood Cholesterol Increased |
2.1% |
Blood Cholesterol |
1.8% |
Prophylaxis |
1.6% |
Toothache |
1.4% |
|
Product Quality Issue |
23.6% |
Vomiting |
15.0% |
Toxic Epidermal Necrolysis |
11.4% |
Nausea |
7.1% |
Acute Hepatic Failure |
3.6% |
Death |
3.6% |
Diarrhoea |
3.6% |
Stevens-johnson Syndrome |
3.6% |
Weight Decreased |
3.6% |
Drug Ineffective |
2.9% |
Fatigue |
2.9% |
Haematochezia |
2.9% |
Hallucination |
2.9% |
Intentional Drug Misuse |
2.9% |
Blood Pressure Increased |
2.1% |
Erythema Multiforme |
2.1% |
Medication Error |
2.1% |
Abdominal Distension |
1.4% |
Abdominal Pain |
1.4% |
Abdominal Pain Upper |
1.4% |
|
Secondary |
Pain |
14.5% |
Product Used For Unknown Indication |
13.3% |
Arthritis |
12.7% |
Drug Use For Unknown Indication |
11.9% |
Back Injury |
8.2% |
Neck Pain |
4.8% |
Hypertension |
4.3% |
Pyrexia |
4.3% |
Headache |
3.9% |
Ill-defined Disorder |
3.1% |
Migraine |
2.8% |
Arthralgia |
2.5% |
Depression |
2.0% |
Diabetes Mellitus |
1.9% |
Pain In Extremity |
1.8% |
Blood Pressure |
1.7% |
Inflammation |
1.6% |
Insomnia |
1.6% |
Back Pain |
1.4% |
Maternal Exposure During Pregnancy |
1.4% |
|
Product Quality Issue |
19.1% |
Vomiting |
12.4% |
Abdominal Pain |
7.7% |
Toxic Epidermal Necrolysis |
7.7% |
Fatigue |
5.3% |
Drug Ineffective |
4.8% |
Drug Administration Error |
4.3% |
Nausea |
3.8% |
Hypersensitivity |
3.3% |
Poisoning Deliberate |
3.3% |
Urticaria |
3.3% |
Gastric Ulcer |
2.9% |
Hallucination |
2.9% |
Intentional Overdose |
2.9% |
Multiple Drug Overdose |
2.9% |
Pyrexia |
2.9% |
Stevens-johnson Syndrome |
2.9% |
Weight Decreased |
2.9% |
Acute Hepatic Failure |
2.4% |
Death |
2.4% |
|
Concomitant |
Product Used For Unknown Indication |
32.8% |
Drug Use For Unknown Indication |
17.6% |
Pain |
7.7% |
Premedication |
6.2% |
Hypertension |
4.5% |
Rheumatoid Arthritis |
3.9% |
Crohn's Disease |
2.5% |
Depression |
2.5% |
Multiple Sclerosis |
2.4% |
Headache |
2.4% |
Multiple Myeloma |
2.3% |
Anxiety |
2.2% |
Prophylaxis |
2.1% |
Osteoporosis |
1.7% |
Nausea |
1.6% |
Contraception |
1.6% |
Asthma |
1.6% |
Atrial Fibrillation |
1.5% |
Constipation |
1.4% |
Gastrooesophageal Reflux Disease |
1.4% |
|
Vomiting |
14.1% |
Weight Decreased |
9.5% |
Pain |
8.0% |
Urinary Tract Infection |
6.6% |
Nausea |
6.4% |
Weight Increased |
5.7% |
Pyrexia |
4.5% |
Fatigue |
4.2% |
Death |
4.0% |
Pneumonia |
4.0% |
Pruritus |
4.0% |
Pulmonary Embolism |
3.9% |
Pain In Extremity |
3.8% |
Headache |
3.6% |
Dyspnoea |
3.1% |
Vision Blurred |
3.1% |
Drug Ineffective |
3.0% |
Flushing |
3.0% |
Tremor |
3.0% |
Arthralgia |
2.7% |
|
Interacting |
Migraine |
30.0% |
Arthritis |
10.0% |
Fibromyalgia |
10.0% |
Myalgia |
10.0% |
Neuralgia |
10.0% |
Non-hodgkin's Lymphoma |
10.0% |
Pain |
10.0% |
Sarcoma |
10.0% |
|
Back Pain |
20.0% |
Chills |
20.0% |
Drug Interaction |
20.0% |
Dyspnoea |
20.0% |
Tooth Infection |
20.0% |
|